2025³â 08¿ù 09ÀÏ Åä¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > Àαⴺ½º

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýȰ

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óǰ

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
 
¸ðµÎ 92622°³ÀÇ ´º½º°¡ °Ë»öµÇ¾ú½À´Ï´Ù.



Çö´ëÂ÷, Çë°¡¸® ¼ö¿äÀÀ´ä±³Åë ½Ã¹ü»ç¾÷ Âü¿©

¼ÅŬ Ç÷§Æû ±Û·Î¹ú »ç¾÷ È®Àå ±â¹Ý ¸¶·Ã
Çö´ëÂ÷°¡ Çë°¡¸®¿¡¼­ Áö¿ª ±³Åë ¹®Á¦¸¦ ÇØ°áÇϱâ À§ÇÑ ¼ö¿äÀÀ´ä±³Åë(Demand Responsive Transport, DRT) ¿î¿µ ½Ã¹ü»ç¾÷¿¡ Âü¿©ÇÑ´Ù. ±¹³» ¼º°øÀûÀÎ ¼ö¿äÀÀ´ä±³Åë ¼­ºñ½º Á¦°ø °æÇèÀ» ¹ÙÅÁÀ¸·Î ±Û·Î¹ú ½ÃÀåÀ¸·Î ¼­ºñ½º È®´ë¸¦ ÃßÁøÇÑ´Ù´Â Á¡¿¡¼­ Àǹ̰¡ ÀÖ´Ù. Çö´ëÀÚµ¿Â÷´Â Áö³­´Þ 31ÀÏ(ÇöÁö½Ã°¢) Çë°¡¸® ±«µÉ·Ú(Gödöllő)½Ã¿¡¼­ ¿­¸° ‘Çë°¡¸® ¼ö¿äÀÀ´ä±³Åë ¼­ºñ½º °³Åë½Ä’¿¡¼­ ÃÖ÷´Ü ¼ö¿äÀÀ´ä±³Åë Ç÷§ÆûÀ» Á¦°øÇϰí, ±Û·Î¹ú »ç¾÷ È®Àå ±â¹ÝÀ» ¸¶·ÃÇÑ´Ù°í 3ÀÏ(ÀÏ) ¹àÇû´Ù. °³Åë½Ä¿¡ µû¶ó 8¿ù 18ÀϺÎÅÍ 10¿ù ...

¡®±ñdzġŲ »À ¹ß¶ó¹ö¸± ¹ß°ñ Àü¹®°¡¡¯ ¸ðÁý¡¦ÀÏ±Þ 100¸¸¿ø

ÀâÄÚ¸®¾Æx¾Ë¹Ù¸óxǪ¶ó´ß º¹³¯ ÀÌ»ö¾Ë¹Ù
ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸ó(´ëÇ¥ÀÌ»ç À±ÇöÁØ)ÀÌ º¹³¯À» ¸Â¾Æ ġŲ Àü¹® ºê·£µå Ǫ¶ó´ß ġŲ°ú ÇÔ²² ÀÌ»ö ¾Ë¹Ù¸¦ ¸ðÁýÇÏ´Â À̺¥Æ®¸¦ ÁøÇàÇÑ´Ù°í 21ÀÏ ¹àÇû´Ù. ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸óÀº ³»´Þ 3ÀϱîÁö Ǫ¶ó´ß ġŲ°ú Çù¾÷ÇØ º¹³¯ ±â³ä ÀÌ»ö °ø°í¸¦ ³»°í ‘±ñdzġŲ »À ¹Ù¸¦ ¾Ë¹Ù¸ó’°ú ‘±ñdzġŲ »À ¹ß¶ó¹ö¸± ¹ß°ñ Àü¹®°¡’¸¦ ¸ðÁýÇÑ´Ù. À̹ø À̺¥Æ®´Â ¾Ë¹Ù¸óÀÌ ÁøÇà ÁßÀÎ ´ë±Ô¸ð ÇÁ·Î¸ð¼Ç ‘2025 ¿©¸§ ¾Ë¹Ù Æä½ºÅ¸(¿©¾ËÆä)’ÀÇ ÀÏȯÀÌ´Ù. ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸óÀº ¿©¸§Ã¶ ¹«´õÀ§¿Í ²ß²ßÇÑ ³¯¾¾·Î ÁöÃÄ ÀÖ´Â ±¸Á÷ÀÚµéÀ» À§ ...

Novotech Report: How In-Vivo CAR-T May Reshape Cell Therapy Econo...
SYDNEY -- With in-vivo CAR-T therapies gaining global momentum, a new whitepaper from Novotech, a leading global full-service clinical Contract Research Organization (CRO) and scientific advisory company, offers insight into this next frontier of immunotherapy. In-Vivo CAR Therapies - Global Research and Development Landscape (2025) report explores the accelerating innovation in in-vivo CAR-T (Chimeric Antigen Receptor) technologies and their potential to reshape treatment across oncology, autoi ...
ºñÆ®¿Í ¹Ù¿î½º °¡µæÇÑ ½ºÆ®¸®Æ® ¹®È­·Î ³ëµé¼¶ÀÌ ¡®µé½â¡¯ (2024-06-06)
¿ìü±¹¹°·ùÁö¿ø´Ü¡¤ºÎ»êÇ׺¸¾È°ø»ç ä¿ë (2024-04-23)
Andersen Expands Reach of Global Valuation Practice to Inclu... (2024-02-17)
Tebahsoft¡¯s AI Learning Solution for CES 2025 Showcase (2024-10-11)
FPT Forges Partnership with Ascending Strategies, Strengthen... (2024-10-11)
SK³×Æ®¿÷½º, Æê ÄÉ¾î ¸®µù ½ºÅ¸Æ®¾÷¿¡ 280¾ï ÅõÀÚ (2023-11-21)
Quectel Releases New 4G/5G, LPWA and GNSS Antennas to Help C... (2023-07-12)
µðÁöÅÐ º¸Çè ´ëÁßÈ­ ³ë¸°´Ù (2024-04-18)
½Ã¿ø½ºÄð·¦, ½ÃÀÛÀÌ ¹Ý ÅäÀÍ È¯±Þ¹Ý ¼ö°­»ý 750Á¡ ´Þ¼º (2018-01-22)
¿¬´ë¿Í »ó»ýÀÇ ¿¹¼úÁ¦ ¡®2023 ¿µµîÆ÷³×Æ®¿öÅ©¿¹¼úÁ¦¡¯ (2023-10-20)
¿©ÀÚ ¾ÆÀ̵¹ÀÌ ¹«Àεµ¿¡¼­ ³ªÈ¦·Î 1¹Ú 2ÀÏ? (2024-03-22)
°ÇÃ๰ À¯Áöº¸¼ö ºÐ¾ßÀÇ ±â¼ú Çõ½Å Çù¾à (2024-05-05)
Àϵ¿Èĵ𽺠¾ÆÀ̾ä, ȨÇ÷¯½º¿Í ÇÔ²² ŰÁî ÄíÅ· Ŭ·¡½º (2024-05-27)
¿¡¾îÀÎõ, ¾Æ½Ã¾Æ³ªÇ×°ø È­¹°±â »ç¾÷ ¸Å°¢ ¿ì¼±Çù»ó´ë»óÀÚ ¼±Á¤ (2024-06-18)
¡®³ª´Â SOLO' 14±â ¡®¹Ì³à »ïÃѻ硯¿Í ¸¸³­ ¡®¹Ì½ºÅÍ¡¯µéÀÇ Á¤Ã¼... (2024-08-01)
NCT Á¦³ë, ÀνºÅ¸±×·¥ ¼Ó 'ijÁÖ¾ó+·°¼Å¸®' ÆÐ¼Ç (2024-02-24)
ESG Ä·ÆäÀÎÀ¸·Î ±âºÎ¿ë µµÀÚ±â ÅÒºí·¯ ¸¸µé±â (2024-05-22)
FPT Software Named a Major Player in IDC MarketScape: Asia/P... (2023-05-09)
KG ¸ðºô¸®Æ¼, 2024³â »ó¹Ý±â ÈæÀÚ ±â·Ï (2024-07-27)
¿¡½ºÁöÀÌ, Çѱ¹µµ·Î°ø»ç∙Çѱ¹¼öÀÚ¿ø°ø»ç ±â¼ú µî·Ï ¿Ï·á (2023-11-23)
Experian Named Overall Leader in KuppingerCole¡¯s 2023 Fraud... (2023-05-26)
Á÷ÀåÀÎ 66.1% 1³â À̳» Åð»ç... '´õ ÁÁÀº °÷À¸·Î ÀÌÁ÷' 1À§ (2024-04-03)
Philip Morris International Demonstrates Clear Progress Towa... (2024-04-03)
¹Ð¿öŰ ¡®M18 8ÀÎÄ¡ üÀÎÅ顯 (2023-01-31)
·Î¿ìÄù½ºÆ®, ³×À̹ö ºê·£µå½ºÅä¾î¼­ ¹«·á ±³È¯ ¹× ¹Ýǰ ¼­ºñ½º (2024-06-08)
       [ÀÌÀü][1]....[675][676][677][678][679][680][681][682][683]...[3705][´ÙÀ½]

°øÁö»çÇ×
´º½ºÁö ÇÑÀÚ Ç¥±â¿¡ ´ë¸¸½Ä À½Â÷ Ç¥±â '纽ÞÙó¢ ´Ï¿ì½ÃÁö' º´±â
º£³×ÇÁ·Ò º£³×ÀÎÅõ Áß¹® Ç¥±â 宝Ò¬ÜØÙÌ 宝Ò¬ì×öõ(ÜÄÒ¬ÜØÙÌ ÜÄ...
¹Ìµð¾î¾Æ¿ì¾î Mediaour ØÚ体ä²们 ØÚô÷ä²Ùú MO ¿¥¿À ØÚä² ØÚä²
¾Ë¸®¿ìºê Alliuv ä¹备: ä¹联êó备, ¾Ë¶ã Althle ä¹÷åìÌ
¾Ë¸®¾Ë Allial Áß¹® Ç¥±â ä¹××尔 ä¹××ì³
´ºÆÛ½ºÆ® New1st Áß¹® Ç¥±â 纽ììãæ(¹øÃ¼ Òïììãæ), N1 纽1
¿£ÄÚ½º¸ð½º : À̾¾ 'EnCosmos : EC' Áß¹® Ç¥±â ì¤ñµ
¾ÆÀ̵ð¾î·Ð Idearon Áß¹® Ç¥±â ì¤îè论 ì¤îèÖå
¹ÙÀÌ¿ÀÀÌ´Ï Bioini Áß¹® Ç¥±â ù±药研 ù±å·æÚ
¿À½ºÇÁ·Ò Ausfrom 奥ÞÙÜØÙÌ, À£ÇÁ·Ò Welfrom 卫ÜØÙÌ
¿¡³ÊÇÁ·Ò Enerfrom 额ÒöÜØÙÌ ¿¡³ÊÀ¯ºñ Eneruv 额Òöêó备
¾ËÇÁ·Ò Alfrom Áß¹® Ç¥±â ä¹尔ÜØÙÌ ä¹ì³ÜØÙÌ
 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇѰè¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, ÆÑ½º 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..